Cargando…
Salinomycin inhibits proliferative vitreoretinopathy formation in a mouse model
Proliferative vitreoretinopathy (PVR) is a progressive disease that develops in a subset of patients who undergo surgery for retinal detachment repair, and results in significant vision loss. PVR is characterized by the migration of retinal pigment epithelial (RPE) cells into the vitreous cavity, wh...
Autores principales: | Heffer, Alison M., Wang, Victor, Libby, Richard T., Feldon, Steven E., Woeller, Collynn F., Kuriyan, Ajay E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751870/ https://www.ncbi.nlm.nih.gov/pubmed/33347461 http://dx.doi.org/10.1371/journal.pone.0243626 |
Ejemplares similares
-
A Mouse Model of Proliferative Vitreoretinopathy Induced by Intravitreal Injection of Gas and RPE Cells
por: Heffer, Alison, et al.
Publicado: (2020) -
The polyether ionophore salinomycin targets multiple cellular pathways to block proliferative vitreoretinopathy pathology
por: Heffer, Alison M., et al.
Publicado: (2019) -
TNF-α and NF-κB signaling play a critical role in cigarette smoke-induced epithelial-mesenchymal transition of retinal pigment epithelial cells in proliferative vitreoretinopathy
por: Wang, Victor, et al.
Publicado: (2022) -
Myo/Nog Cells Give Rise to Myofibroblasts During Epiretinal Membrane Formation in a Mouse Model of Proliferative Vitreoretinopathy
por: Crispin, Mara, et al.
Publicado: (2023) -
Proton pump inhibitors attenuate myofibroblast formation associated with thyroid eye disease through the aryl hydrocarbon receptor
por: Hammond, Christine L., et al.
Publicado: (2019)